News
Findings could help explain the links between macular degeneration and cardiovascular disease, which both worsen with age.
A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...
4h
News-Medical.Net on MSNStudy identifies potential way to slow or block progression of age-related macular degenerationA new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression ...
Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the market for age-related macular degeneration is ...
Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage ...
NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related macular degeneration (AMD).
"We are committed to bringing the first sustained-release tyrosine kinase inhibitor (TKI) to market for patients and physicians in need of a new treatment option for wet AMD. With both pivotal trials ...
EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration Provided by GlobeNewswire May 27, 2025, 11:00:00 AM ...
The Business Research Company's Juvenile Macular Degeneration Treatment Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 27 ...
– Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest – – LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results